Immutep (IMMP) Total Current Liabilities (2011 - 2025)
Immutep's (IMMP) quarterly Total Current Liabilities came in at $30.9 million in Q4 2025, up 412.38% YoY from $6.0 million in Q4 2024, and up 277.75% on a QoQ basis from $8.2 million in Q2 2025.
Immutep (IMMP) Total Current Liabilities (2011 - 2025) Analysis & Trends
Immutep (IMMP) has 15 years of Total Current Liabilities data on file, last reported at $30.9 million in Q4 2025.
- Quarterly Total Current Liabilities rose 412.38% year-over-year to $30.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.9 million (up 412.38% YoY) and the FY2025 annual result came in at $8.2 million, up 18.24% from the prior year.
- Total Current Liabilities rose to $30.9 million in Q4 2025, from $8.2 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $30.9 million in Q4 2025 to a low of $4.1 million in Q2 2021.
- A 5-year average of $8.3 million and a median of $5.9 million in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities fell 22.49% — and 2025, when it soared 412.38%.
- Tracing IMMP's Total Current Liabilities over 5 years: stood at $5.7 million in 2021, then dropped by 3.73% to $5.5 million in 2022, then retreated by 22.49% to $4.3 million in 2023, then jumped by 41.14% to $6.0 million in 2024, then soared by 412.38% to $30.9 million in 2025.
- The last three Total Current Liabilities figures came in at $30.9 million (Q4 2025), $8.2 million (Q2 2025), and $6.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 630.93 Mn |
| 10 | Immutep | 56.17 Mn | -8.92 Mn | - | 30.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.87 Mn |
| Jun 30, 2025 | 8.17 Mn |
| Dec 31, 2024 | 6.02 Mn |
| Jun 30, 2024 | 6.91 Mn |
| Dec 31, 2023 | 4.27 Mn |
| Jun 30, 2023 | 6.53 Mn |
| Dec 31, 2022 | 5.51 Mn |
| Jun 30, 2022 | 4.59 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Jun 30, 2021 | 4.11 Mn |
| Dec 31, 2020 | 3.81 Mn |
| Jun 30, 2020 | 2.20 Mn |
| Dec 31, 2019 | 2.71 Mn |
| Jun 30, 2019 | 3.71 Mn |
| Dec 31, 2018 | 2.96 Mn |
| Jun 30, 2018 | 2.92 Mn |
| Jun 30, 2017 | 1.98 Mn |
| Mar 31, 2017 | 951,285.54 |
| Jun 30, 2016 | 1.10 Mn |
| Jun 30, 2015 | 3.40 Mn |